Contact Us
Drug Search Results
More Filters [+]

Pentazocine

Alternative Names: pentazocine, talwin, talacen
Latest Update: 2024-10-29
Latest Update Note: News Article

Product Description

Pentazocine injection is used to relieve moderate to severe pain. It may also be used before surgery or with a general anesthetic (medicine that puts you to sleep). Pentazocine belongs to the group of medicines called narcotic analgesics (pain medicines). It acts on the central nervous system (CNS) to relieve pain. (Sourced from: https://www.mayoclinic.org/drugs-supplements/pentazocine-injection-route/side-effects/drg-20074265?p=1)

Mechanisms of Action: OPRK Agonist,OPRM Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous,Intramuscular,Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Australia | Bangladesh | Canada | Greece | India | Ireland | Italy | Korea | Malaysia | New Zealand | Pakistan | Peru | Poland | Portugal | Slovenia | South Africa | Taiwan | United Kingdom | United States

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Pentazocine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title

10/29/2024

News Article

 Protega Pharmaceuticals Receives FDA Approval for ROXYBOND™ (oxycodone hydrochloride) Immediate-Release 10 mg Tablet with Abuse-Deterrent Technology for Management of Pain

08/26/2024

News Article

 Indivior Announces BARDA's First Order of OPVEE® to Combat Opioids and Aid in National Preparedness

08/07/2024

News Article

 FDA Approves Zurnai™ (nalmefene injection) Auto-Injector for the Emergency Treatment of Known or Suspected Opioid Overdose Induced by Natural or Synthetic Opioids in Adults and Pediatric Patients 12 Years and Older

06/18/2024

News Article

 Indivior Announces the Publication of New Data on the Comparative Effectiveness of Intranasal (IN) Nalmefene (OPVEE 2.7mg) and IN Naloxone (4 mg) in a Translational Model Assessing the Impact of a Synthetic Opioid Overdose on Respiratory Depression and Cardiac Arrest

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions